NIH Funding Cycles 2026: Standard Due Dates, the Resubmission Shift, and the Review-to-Award Timeline

Almost every guide to National Institutes of Health (NIH) deadlines makes the same mistake: it lists three dates in isolation and stops. That leaves applicants asking the questions the date list never answers. Why is the resubmission deadline a month later? Which cycle does my application actually compete in? When does the money arrive? The honest answer is that NIH funding cycles are not three dates. They are a two-axis system, your activity code (R01, R21, R15, or SBIR) crossed with your application type (new, resubmission, or renewal), read off against three standing cycles that each carry a fixed submission-to-award timeline. This page is the mechanic-explainer: the single canonical view of how the cycles work, why the dates move, and what happens in the roughly nine to ten months after you hit submit. Planning a specific mechanism right now? Run your dates through our NIH deadline calculator before you build a timeline.

What are the NIH funding cycles?

The NIH funding cycles are three annual review-and-award cycles, labeled Cycle I, Cycle II, and Cycle III, each of which pairs a submission window with a fixed downstream timeline of peer review, Advisory Council review, and award. Per the NIH Standard Due Dates policy, new non-AIDS R01 applications are due February 5 for Cycle I, June 5 for Cycle II, and October 5 for Cycle IIIverified 2026-06-10; other mechanisms ride the same cycles on a different day (the R21 on the 16th, the R15 on the 25th), which the matrix below lays out in full. The cycle is not just the date you submit; it is the lane your application rides all the way to the funding decision, and every application competes against others in the same cycle.

The three cycles exist because NIH cannot review tens of thousands of applications continuously. Batching them into quarters lets CSR (the CSR) assign applications to study sections, convene review panels, and feed results into the relevant Advisory Council meeting. The NIAID review-cycle overview from the National Institute of Allergy and Infectious Diseases (NIAID) lays out how the three windows map to cycles I, II, and III. Understanding the cycle is what lets you work backward from the award you want to the date you must submit.

How do activity code and application type set the date?

The NIH due date you owe is the intersection of two axes: your activity code (the grant mechanism) and your application type (new versus resubmission versus renewal). Competitors publish a flat list and leave you to guess which row is yours. The matrix below is the actual decision surface. Read across your mechanism, then down your application type, and the date is the cell where they meet.

Worked backward-planning example: a Cycle I new R01

The matrix gives you a date; the table below shows what that date actually buys you, stage by stage, all the way to the money. This is the chain you read backward when you have a target start date and need to know which deadline is your real hard wall. Every row is mapped to the cycle structure published on the NIH Standard Due Dates page, which lists Cycle I new R01 receipt as February 5, scientific-merit (peer) review in June or July, Advisory Council in August or October, and the earliest project start in September or December. Where NIH itself publishes a range, this example takes the later branch (October Council, December start), because planning to the later branch never makes you late.

Net span: roughly nine to ten months from the February 5 submission to the earliest December award. Read it backward: to spend FY-2027 money on a project, lock February 5 as your hard deadline, then back up a further two to three weeks for institutional sign-off and the eRA Commons error-correction buffer. Honest hedge: the exact Council month and start date vary by Institute, cycle, and appropriations; NIH publishes August-or-October and September-or-December as ranges, so treat December 2026 as the earliest plausible award, not a guaranteed one.

Three structural facts make this matrix legible. First, the mechanisms share the same three cycles but not the same day of the month: a new R01 is due on the 5th (February 5, June 5, October 5), a new R21 on the 16th (February 16, June 16, October 16), and a new R15 on the 25th (February 25, June 25, October 25), per the NIH R01 activity-code page, the NIH R21 activity-code page with Parent R21 PA-25-304, and the NIH R15 activity-code page with AREA parent R15 NOFO PAR-25-134. Second, the resubmission column shifts one month later for R01 and R21 (to March 5 / July 5 / November 5 and March 16 / July 16 / November 16 respectively), but R15 resubmissions stay on the same February 25 / June 25 / October 25 dates as new R15 applications. Third, the mechanism changes the application content even when the cycle matches: the R01 allows a 12-page Research Strategy over a project period of up to five years, while the R21 caps the Research Strategy at six pages, runs two years, requires no preliminary data, and cannot be renewed, as the Parent R21 announcement PA-25-304 spells out.

One large-budget rule recently changed in applicants' favor. Historically, requesting $500,000 or more in direct costsverified 2026-06-10 in any single year required NIH program-staff approval at least six weeks before submission. That pre-submission approval requirement was eliminated effective per Guide Notice NOT-OD-26-019 in December 2025, removing a planning bottleneck for ambitious budgets. The change does not alter the due dates themselves, but it removes a step that used to force big-budget applicants to start their conversation with program staff even earlier than the timeline below suggests. If you run a startup or small business weighing non-dilutive research dollars against the tax treatment of your own R&D spend, our sister publication CeoCult breaks down the interplay in Section 174 R&D capitalization for software founders.

Why is the resubmission deadline one month later?

The NIH resubmission deadline is one month later than the new-application deadline because NIH deliberately builds in time for applicants to respond to a prior review. Per the standard due dates and the NIAID overview of the R01 process, R01 resubmission (A1), renewal, and revision applications use the shifted dates of March 5, July 5, and November 5, exactly one month after the February 5, June 5, and October 5 new R01 dates (the R21 shift works the same way, one month after the 16th to March 16, July 16, and November 16; the R15 is the exception, with resubmissions on the same February 25, June 25, and October 25 dates as new applications). The extra month exists so that an applicant who received a summary statement from the prior cycle can read the critique, revise the science, and write the one-page introduction that responds to reviewers, all before the resubmission window closes.

This is the single most misunderstood feature of the calendar, and it produces a counterintuitive but important consequence: the later date does not buy you a later review. An A1 submitted by March 5 still competes in Cycle I, alongside the February 5 new applications, and rides the same review-to-award timeline. The month is for revision work, not for delay. A renewal (formerly called a competing continuation) and a revision follow the same one-month-later logic for the same reason: each builds on prior work that needs to be summarized and updated before submission.

What happens between submission and award?

Between submission and award, an NIH application moves through a fixed two-level review sequence that takes roughly nine to ten months end to end. The path is the same regardless of activity code, and knowing it is what turns "I submitted in February" into "I should plan around a fall funding decision." Per the NIAID due-dates and review-cycle guidance, a typical Cycle I application submitted around February or March undergoes peer review around June or July and reaches second-level Advisory Council review at the October Council meeting.

The practical lesson is to read the calendar backward. If you need funding to start in a given fiscal year, count back roughly nine to ten months to find the cycle you must hit, then back another few weeks for institutional sign-off and the error-correction buffer. The eRA Commons validation step is where many first-time applicants lose a day they did not budget for, because errors flagged at submission must be corrected before the application is considered on time.

This page is the cycle hub for every NIH mechanism on GrantProbe. For the deep profile of the flagship mechanism, including budget structure, eligibility, and review criteria, see our NIH R01 Research Project Grant profile, which uses these same standard due dates. For the small-business path and its separate receipt calendar, see our NIH SBIR and STTR grants guide.

What changed with the AIDS due dates in 2026?

The biggest live change to the NIH calendar in 2026 is the elimination of the dedicated AIDS application due dates. For decades, AIDS-related applications used a separate, later set of receipt dates from the rest of NIH. That separate calendar is ending. Per the NIH and National Library of Medicine grant-deadlines page and the standard due dates policy, beginning with applications for Advisory Council review in January 2027, which corresponds to due dates on or after May 25, 2026, NIH eliminates dedicated AIDS application due dates, and AIDS-related applications then use the same standard due dates as all other applications. The final AIDS-specific deadline was the Cycle 1 date of May 7, 2026verified 2026-06-10.

The practical effect is a simpler, single calendar. An AIDS-focused investigator who once tracked two sets of dates now tracks one. The trade-off is that the longer preparation window the AIDS calendar historically offered is gone, so investigators who relied on the later dates should rebuild their backward plan around the standard cycle and its roughly nine-to-ten-month review-to-award timeline.

What does "5:00 PM local time" mean for the deadline?

NIH applications are due by 5:00 PM local time of the applicant organizationverified 2026-06-10 on the specified due date, per the NIH standard due dates policy. The deadline keys to the time zone of the applicant institution, not to a single national cutoff. A San Francisco institution submits against 5:00 PM Pacific; a Boston institution against 5:00 PM Eastern. This sounds like a generous detail, but it is a trap for multi-site collaborations and for individuals confused about which clock governs.

Because the validation and error-correction window can consume hours, NIH advises submitting well before the deadline rather than at the last legal minute. The submission is not final the moment Grants.gov accepts it; it must pass eRA Commons validation, and any errors must be corrected before the deadline for the application to count as on time. The safest discipline is to treat the deadline as the morning of the due date, not 5:00 PM, so a flagged error does not cost you a full cycle.

Frequently asked questions

Bottom line

NIH funding cycles are not three dates to memorize; they are a two-axis system to read. Cross your activity code (R01, R21, R15, or SBIR) with your application type (new, resubmission, or renewal) and the date falls out: new non-AIDS applications hit February 5, June 5, or October 5, and resubmissions, renewals, and revisions shift one month later to March 5, July 5, or November 5. The shift exists to give you time to answer a prior review, not to delay it, so an A1 still competes in its original cycle. From submission, plan for roughly nine to ten months through study-section review, the Advisory Council meeting, and the award, and submit before 5:00 PM local time of your own organization. In 2026, the dedicated AIDS due dates end after the final May 7, 2026 date, collapsing two calendars into one. Run your mechanism through our NIH deadline calculator, then read the full NIH R01 grant profile and our NIH SBIR and STTR guide for mechanism-specific detail.

1. NIH, Standard Due Dates (Feb 5 / Jun 5 / Oct 5 new; Mar 5 / Jul 5 / Nov 5 resubmission; 5:00 PM local-time rule; AIDS due-date elimination) verified 2026-06-10.
2. NIAID, Understand Standard Due Dates and Review Cycles (cycle-to-review-to-Council timeline) verified 2026-06-10.
3. NIAID, Overview of the R01 Process (shifted resubmission dates) verified 2026-06-10.
4. NIH, Activity Code R21 and Parent R21 PA-25-304 ($275,000 / two-year cap, 6-page strategy, no renewal) verified 2026-06-10.
5. NIH, Activity Code R01 and Parent R01 PA-25-302 (12-page strategy, up to 5-year project period) verified 2026-06-10.
6. NIH, Activity Code R15 and AREA parent R15 NOFO PAR-25-134 (up to $375,000 direct over a project period of up to 3 years) verified 2026-06-10.
7. NIH / NLM, Grant Deadlines and Submission (final AIDS deadline May 7, 2026) verified 2026-06-10.